FT News in Focus

Big pharma still makes billions after patents lapse


Listen Later

Doctors in the US are wasting hundreds of millions of dollars a year prescribing expensive branded medicines even when cheaper generic alternatives are available, according to an FT analysis. David Crow and Sujeet Indap discuss the findings.

Hosted on Acast. See acast.com/privacy for more information.

...more
View all episodesView all episodes
Download on the App Store

FT News in FocusBy Financial Times